PROPANC BIOPHARMA INC (PPCB:NASDAQ)

$1.62 -0.12 (-6.8966%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 78

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed PROPANC BIOPHARMA INC (PPCB:NASDAQ) News Sources

Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market

05-02-2026

yahoo.com

Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results

18-02-2026

yahoo.com

Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models

03-03-2026

yahoo.com

Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study

10-03-2026

yahoo.com

Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy

12-03-2026

yahoo.com

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain

24-03-2026

yahoo.com

Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans

14-05-2026

yahoo.com

Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results

15-05-2026

yahoo.com

Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients

19-05-2026

yahoo.com

Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade

20-05-2026

yahoo.com

PROPANC BIOPHARMA INC (PPCB:NASDAQ) Sentiment Trend

0 25 50 75 100 90 61 90 79 88 65 83 65 78 79 05-02-2026 18-02-2026 03-03-2026 10-03-2026 12-03-2026 24-03-2026 14-05-2026 15-05-2026 19-05-2026 20-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

PROPANC BIOPHARMA INC (PPCB:NASDAQ) FAQs

toggle

What is the current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ)?

The current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ) is $1.62.


toggle

PROPANC BIOPHARMA INC (PPCB:NASDAQ) absolute price change since previous trading day?

The absolute price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is $-0.12.


toggle

PROPANC BIOPHARMA INC (PPCB:NASDAQ) percentage price change since previous trading day?

The percentage price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is -6.8966%.


toggle

What is the most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?

The most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is 78 out of 100.


toggle

What is the most recent average sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?

The most recent sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is .


SEC-8K** Filing Available For PROPANC BIOPHARMA INC (PPCB:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.